A brief history of triplet repeat diseases -- Huntington's disease and cell therapies: Past, present, and future -- Transcranial two-photon imaging of synaptic structures in the cortex of awake head-restrained mice -- In vivo imaging of synapse plasticity in the mouse motor cortex -- Pluripotent hybrid stem cells from transgenic Huntington's disease monkey -- Mesenchymal stem cells for trinucleotide repeat disorders -- Lentiviral-mediated gene transfer of siRNAs for the treatment of Huntington's disease -- Purification of dFMR1-containing complexes using tandem affinity purification -- Combined FISH and immunofluorescent staining methods to co-localize proteins and mRNA in neurons and brain tissue -- Epigenetic modifications of the FMR1 gene -- The CGG repeat and the FMR1 gene -- Study of oxidative damage and antioxidant systems in two Huntington's disease rodent models -- Regulation of ataxin-1 phosphorylation and its impact on biology -- Towards understanding region-specificity of triplet repeat diseases: Coupled immunohistology and mass spectrometry imaging -- Antibodies and intrabodies against huntingtin: Production and screening of monoclonals and single-chain recombinant forms -- Cell recovery from DM1 transgenic mouse tissue to study (CTG) n instability and DM1 pathogenesis -- Markerless modification of trinucleotide repeat loci in BACs -- DRPLA: Recent advances in research using transgenic mouse models